acetazolamide has been researched along with Arterial Occlusive Diseases in 48 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Patients should be informed of such adverse effects of intravenous acetazolamide administration prior to the acetazolamide challenge test for evaluation of cerebrovascular reactivity." | 2.76 | Adverse effects of intravenous acetazolamide administration for evaluation of cerebrovascular reactivity using brain perfusion single-photon emission computed tomography in patients with major cerebral artery steno-occlusive diseases. ( Kobayashi, M; Kubo, Y; Kuroda, H; Ogasawara, K; Ogawa, A; Saito, H; Suzuki, T; Yoshida, K, 2011) |
| "Nine patients symptomatic with transient ischemic attacks and strokes, and with occlusive vascular disease were studied." | 1.33 | Differentiating hemodynamic compromise by the OEF response to acetazolamide in occlusive vascular disease. ( Chang, Y; Gebel, J; Hammer, MD; Jovin, T; Kuwabara, H; Nemoto, EM; Pindzola, R; Sashin, D; Wechsler, L; Yonas, H, 2005) |
| "Acetazolamide (1 g) was tested in 15 volunteers (age, 28+/-8 years)." | 1.30 | Influence of acetazolamide and CO2 on extracranial flow volume and intracranial blood flow velocity. ( Bähr, RR; Buss, E; Eicke, BM; Hajak, G; Paulus, W, 1999) |
| "The acetazolamide-induced increase of cerebral blood flow could be reliably monitored by increase of cerebral 99mTc-HMPAO uptake, which varied between 11." | 1.28 | 99mTc-HMPAO-SPECT with acetazolamide challenge to detect hemodynamic compromise in occlusive cerebrovascular disease. ( Fuchs, C; Knop, J; Siepmann, G; Thie, A; Zeumer, H, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (6.25) | 18.7374 |
| 1990's | 26 (54.17) | 18.2507 |
| 2000's | 13 (27.08) | 29.6817 |
| 2010's | 6 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shi, H | 1 |
| Liang, LL | 1 |
| Cui, ZH | 1 |
| Siero, JC | 1 |
| Hartkamp, NS | 1 |
| Donahue, MJ | 1 |
| Harteveld, AA | 1 |
| Compter, A | 1 |
| Petersen, ET | 1 |
| Hendrikse, J | 1 |
| Wu, J | 1 |
| Dehkharghani, S | 1 |
| Nahab, F | 1 |
| Qiu, D | 1 |
| Saito, H | 1 |
| Ogasawara, K | 3 |
| Suzuki, T | 2 |
| Kuroda, H | 2 |
| Kobayashi, M | 3 |
| Yoshida, K | 2 |
| Kubo, Y | 2 |
| Ogawa, A | 3 |
| Chida, K | 1 |
| Aso, K | 1 |
| Terasaki, K | 2 |
| Fujiwara, S | 1 |
| Inoue, T | 1 |
| Fujimura, M | 1 |
| Shimizu, H | 1 |
| Takahashi, Y | 1 |
| Tominaga, T | 1 |
| Yamauchi, H | 3 |
| Okazawa, H | 3 |
| Kishibe, Y | 1 |
| Sugimoto, K | 3 |
| Takahashi, M | 2 |
| Fujimoto, S | 1 |
| Hasegawa, Y | 4 |
| Yokota, C | 3 |
| Tagaya, M | 1 |
| Hayashida, K | 2 |
| Yamaguchi, T | 4 |
| Minematsu, K | 4 |
| Ito, H | 1 |
| Sasoh, M | 1 |
| Okuguchi, T | 1 |
| Yukawa, H | 1 |
| Toyoda, H | 1 |
| Fujibayashi, Y | 1 |
| Yonekura, Y | 2 |
| Kuroda, S | 2 |
| Shiga, T | 1 |
| Ishikawa, T | 1 |
| Houkin, K | 1 |
| Narita, T | 1 |
| Katoh, C | 1 |
| Tamaki, N | 1 |
| Iwasaki, Y | 1 |
| Nemoto, EM | 2 |
| Yonas, H | 3 |
| Kuwabara, H | 2 |
| Pindzola, R | 1 |
| Sashin, D | 2 |
| Chang, Y | 2 |
| Jovin, T | 2 |
| Gebel, J | 1 |
| Hammer, MD | 1 |
| Wechsler, L | 1 |
| Kimura, Y | 1 |
| Oku, N | 1 |
| Kajimoto, K | 1 |
| Katoh, H | 1 |
| Tanaka, MR | 1 |
| Takasawa, M | 1 |
| Imaizumi, M | 1 |
| Kitagawa, K | 1 |
| Hori, M | 1 |
| Hatazawa, J | 1 |
| Pindzola, RR | 2 |
| Kuwabara, Y | 3 |
| Ichiya, Y | 3 |
| Sasaki, M | 3 |
| Yoshida, T | 3 |
| Masuda, K | 3 |
| Zbornikova, V | 3 |
| Lassvik, C | 2 |
| Hillman, J | 1 |
| Swenson, ER | 1 |
| Graham, MM | 1 |
| Hlastala, MP | 1 |
| Soricelli, A | 1 |
| Postiglione, A | 1 |
| Cuocolo, A | 1 |
| De Chiara, S | 1 |
| Ruocco, A | 1 |
| Brunetti, A | 1 |
| Salvatore, M | 1 |
| Ell, PJ | 1 |
| Akashi, Y | 1 |
| Fukumura, T | 2 |
| Fujii, K | 2 |
| Fukui, M | 2 |
| Mandai, K | 2 |
| Sueyoshi, K | 2 |
| Fukunaga, R | 2 |
| Nukada, M | 2 |
| Ohtani, F | 1 |
| Araki, Y | 1 |
| Tsukaguchi, I | 2 |
| Abe, H | 1 |
| Hirano, T | 1 |
| Tanaka, Y | 1 |
| Matsumoto, M | 1 |
| Kamada, T | 1 |
| Machac, J | 1 |
| Vallabhajosula, S | 1 |
| Chimowitz, MI | 1 |
| Furlan, AJ | 1 |
| Jones, SC | 1 |
| Sila, CA | 1 |
| Lorig, RL | 1 |
| Paranandi, L | 1 |
| Beck, GJ | 1 |
| Müller, M | 1 |
| Schimrigk, K | 1 |
| Takeuchi, R | 1 |
| Matsuda, H | 1 |
| Sakahara, H | 1 |
| Konishi, J | 1 |
| Ulrich, PT | 1 |
| Kroppenstedt, S | 1 |
| Heimann, A | 1 |
| Kempski, O | 1 |
| Mizumura, S | 1 |
| Kumita, S | 1 |
| Cho, K | 1 |
| Ishihara, M | 1 |
| Kijima, T | 1 |
| Nakajo, H | 1 |
| Kumazaki, T | 1 |
| Eicke, BM | 1 |
| Buss, E | 1 |
| Bähr, RR | 1 |
| Hajak, G | 1 |
| Paulus, W | 1 |
| Cao, B | 1 |
| Kikuchi, K | 1 |
| Murase, K | 1 |
| Miki, H | 1 |
| Kikuchi, T | 1 |
| Sugawara, Y | 1 |
| Mochizuki, T | 1 |
| Ikezoe, J | 1 |
| Ohue, S | 1 |
| Ozgur, HT | 1 |
| Kent Walsh, T | 1 |
| Masaryk, A | 1 |
| Seeger, JF | 1 |
| Williams, W | 1 |
| Krupinski, E | 1 |
| Melgar, M | 1 |
| Labadie, E | 1 |
| Eastwood, JD | 1 |
| Alexander, MJ | 1 |
| Petrella, JR | 1 |
| Provenzale, JM | 1 |
| Vorstrup, S | 1 |
| Sjöholm, H | 1 |
| Skoglund, L | 1 |
| Ryding, E | 1 |
| Knop, J | 1 |
| Thie, A | 1 |
| Fuchs, C | 1 |
| Siepmann, G | 1 |
| Zeumer, H | 1 |
| Karnik, R | 1 |
| Valentin, A | 1 |
| Ammerer, HP | 1 |
| Donath, P | 1 |
| Slany, J | 1 |
| Ringelstein, EB | 1 |
| Van Eyck, S | 1 |
| Mertens, I | 1 |
| Burt, RW | 1 |
| Witt, RM | 1 |
| Cikrit, DF | 1 |
| Reddy, RV | 1 |
| Yonekawa, Y | 1 |
| Kawano, T | 1 |
| Miyake, H | 1 |
| Yamashita, K | 1 |
| Tanaka, K | 1 |
| Gotoh, Y | 1 |
| Handa, H | 1 |
| Takahashi, S | 1 |
| Nyberg-Hansen, R | 2 |
| Russell, D | 2 |
| Rootwelt, K | 1 |
| Sunada, I | 1 |
| Kerty, E | 1 |
| Bakke, SJ | 1 |
| Rootwell, K | 1 |
| Ffytche, TJ | 1 |
1 review available for acetazolamide and Arterial Occlusive Diseases
| Article | Year |
|---|---|
A rationalization of treatment of central retinal artery occlusion.
Topics: Acetazolamide; Arterial Occlusive Diseases; Arteriosclerosis; Arteritis; Blood Sedimentation; Emboli | 1974 |
9 trials available for acetazolamide and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Adverse effects of intravenous acetazolamide administration for evaluation of cerebrovascular reactivity using brain perfusion single-photon emission computed tomography in patients with major cerebral artery steno-occlusive diseases.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Carbonic Anhydrase Inhib | 2011 |
Reduced blood flow response to acetazolamide reflects pre-existing vasodilation and decreased oxygen metabolism in major cerebral arterial occlusive disease.
Topics: Acetazolamide; Arterial Occlusive Diseases; Blood Flow Velocity; Brain; Carotid Artery Thrombosis; C | 2002 |
Quantitative measurement of regional cerebrovascular reactivity to acetazolamide using 123I-N-isopropyl-p-iodoamphetamine autoradiography with SPECT: validation study using H2 15O with PET.
Topics: Acetazolamide; Adult; Aged; Arterial Occlusive Diseases; Autoradiography; Cerebral Arteries; Cerebro | 2003 |
Differences in vasodilatory capacity and changes in cerebral blood flow induced by acetazolamide in patients with cerebrovascular disease.
Topics: Acetazolamide; Adult; Aged; Arterial Occlusive Diseases; Blood Flow Velocity; Brain; Cerebral Arteri | 2003 |
Relationship between vasodilatation and cerebral blood flow increase in impaired hemodynamics: a PET study with the acetazolamide test in cerebrovascular disease.
Topics: Acetazolamide; Aged; Arterial Occlusive Diseases; Brain; Cerebral Arterial Diseases; Cerebrovascular | 2003 |
Reduced blood flow and preserved vasoreactivity characterize oxygen hypometabolism due to incomplete infarction in occlusive carotid artery diseases.
Topics: Acetazolamide; Aged; Arterial Occlusive Diseases; Brain; Cerebral Infarction; Cerebrovascular Circul | 2004 |
[Pre and post operative evaluation of the perfusion reserve by acetazolamide 99mTc-HMPAO SPECT in patients with chronic occlusive cerebral arteries: a comparative study with PET].
Topics: Acetazolamide; Adult; Aged; Arterial Occlusive Diseases; Cerebral Arterial Diseases; Cerebral Revasc | 1994 |
Noninvasive quantitative measurements of regional cerebral blood flow using technetium-99m-L,L-ECD SPECT activated with acetazolamide: quantification analysis by equal-volume-split 99mTc-ECD consecutive SPECT method.
Topics: Acetazolamide; Adult; Aged; Arterial Occlusive Diseases; Carotid Stenosis; Cerebral Arterial Disease | 1997 |
Evaluation of vasomotor reactivity by transcranial Doppler and acetazolamide test before and after extracranial-intracranial bypass in patients with internal carotid artery occlusion.
Topics: Acetazolamide; Aged; Arterial Occlusive Diseases; Carotid Artery Diseases; Cerebral Revascularizatio | 1992 |
38 other studies available for acetazolamide and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Ophthalmic Artery Occlusion After Cosmetic Facial Filler Injections.
Topics: Acetazolamide; Arterial Occlusive Diseases; Cosmetic Techniques; Dermal Fillers; Diuretics; Female; | 2018 |
Neuronal activation induced BOLD and CBF responses upon acetazolamide administration in patients with steno-occlusive artery disease.
Topics: Acetazolamide; Aged; Arterial Occlusive Diseases; Brain; Carbonic Anhydrase Inhibitors; Cerebrovascu | 2015 |
Acetazolamide-augmented dynamic BOLD (aczBOLD) imaging for assessing cerebrovascular reactivity in chronic steno-occlusive disease of the anterior circulation: An initial experience.
Topics: Acetazolamide; Adult; Aged; Arterial Occlusive Diseases; Carbonic Anhydrase Inhibitors; Cerebrovascu | 2017 |
Accuracy of central benzodiazepine receptor binding potential/cerebral blood flow SPECT imaging for detecting misery perfusion in patients with unilateral major cerebral artery occlusive diseases: comparison with cerebrovascular reactivity to acetazolamid
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Area Under Curve; Arterial Occlusive Diseases; Carbon | 2012 |
Quantitative assessment of cerebral hemodynamics using single photon emission computed tomography with venous blood sampling.
Topics: Acetazolamide; Adult; Aged; Arterial Occlusive Diseases; Brain; Cerebrovascular Circulation; Cerebro | 2013 |
Acetazolamide challenge test using semiquantitative 123 I-IMP SPECT for detection of cerebral misery perfusion.
Topics: Acetazolamide; Aged; Arterial Occlusive Diseases; Blood Volume; Carbonic Anhydrase Inhibitors; Cereb | 2002 |
Differentiating hemodynamic compromise by the OEF response to acetazolamide in occlusive vascular disease.
Topics: Acetazolamide; Adult; Aged; Arterial Occlusive Diseases; Female; Hemodynamics; Humans; Ischemic Atta | 2005 |
Diastolic blood pressure influences cerebrovascular reactivity measured by means of 123I-iodoamphetamine brain single photon emission computed tomography in medically treated patients with occlusive carotid or middle cerebral artery disease.
Topics: Acetazolamide; Aged; Arterial Occlusive Diseases; Blood Pressure; Brain; Carotid Artery Diseases; Ce | 2006 |
PET OEF reactivity for hemodynamic compromise in occlusive vascular disease.
Topics: Acetazolamide; Adult; Aged; Arterial Occlusive Diseases; Brain; Carotid Stenosis; Cerebral Arterial | 2007 |
Time dependency of the acetazolamide effect on cerebral hemodynamics in patients with chronic occlusive cerebral arteries. Early steal phenomenon demonstrated by [15O]H2O positron emission tomography.
Topics: Acetazolamide; Aged; Arterial Occlusive Diseases; Blood Pressure; Brain Ischemia; Carotid Artery, In | 1995 |
Intracranial haemodynamics during vasomotor stress test in unilateral internal carotid artery occlusion estimated by 3-D transcranial Doppler scanner.
Topics: Acetazolamide; Aged; Arterial Occlusive Diseases; Blood Flow Velocity; Carotid Artery Diseases; Cere | 1995 |
Acetazolamide slows VA/Q matching after changes in regional blood flow.
Topics: Acetazolamide; Animals; Arterial Occlusive Diseases; Blood Flow Velocity; Carbonic Anhydrases; Disea | 1995 |
Effect of adenosine on cerebral blood flow as evaluated by single-photon emission computed tomography in normal subjects and in patients with occlusive carotid disease. A comparison with acetazolamide.
Topics: Acetazolamide; Adenosine; Aged; Arterial Occlusive Diseases; Basal Ganglia; Carotid Artery, Internal | 1995 |
Acetazolamide challenge for three-dimensional time-of-flight MR angiography of the brain.
Topics: Acetazolamide; Adult; Aged; Angiography, Digital Subtraction; Arterial Occlusive Diseases; Arteries; | 1994 |
Acetazolamide reactivity on 123I-IMP single photon emission computed tomography in patients with major cerebral artery occlusive disease: correlation with positron emission tomography parameters.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Amphetamines; Arterial Occlusive Diseases; Cerebral A | 1994 |
Evaluation of cerebral vasoreactivity by three-dimensional time-of-flight magnetic resonance angiography.
Topics: Acetazolamide; Adult; Aged; Arterial Occlusive Diseases; Brain Ischemia; Cerebral Angiography; Cereb | 1994 |
Cerebral versus myocardial stress perfusion imaging: role of pharmacological intervention in the diagnostic assessment of flow reserve.
Topics: Acetazolamide; Arterial Occlusive Diseases; Carbon Dioxide; Cerebrovascular Circulation; Cerebrovasc | 1994 |
Transcranial Doppler assessment of cerebral perfusion reserve in patients with carotid occlusive disease and no evidence of cerebral infarction.
Topics: Acetazolamide; Aged; Arterial Occlusive Diseases; Blood Flow Velocity; Carotid Artery Diseases; Cere | 1993 |
Vasomotor reactivity and pattern of collateral blood flow in severe occlusive carotid artery disease.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Blood Flow Velocity; Car | 1996 |
Relationship between the flow pattern and vasomotor reactivity in the ophthalmic artery, siphon and vessels within the circle of Willis in the unilateral internal carotid artery occlusion.
Topics: Acetazolamide; Aged; Anticonvulsants; Arterial Occlusive Diseases; Blood Flow Velocity; Carotid Arte | 1996 |
Effect of acetazolamide reactivity on [corrected] long-term outcome in patients with major cerebral artery occlusive diseases.
Topics: Acetazolamide; Adult; Aged; Arterial Occlusive Diseases; Blood Pressure; Cerebral Arteries; Cerebrov | 1998 |
PET evaluation of cerebral hemodynamics in occlusive cerebrovascular disease pre- and postsurgery.
Topics: Acetazolamide; Arterial Occlusive Diseases; Brain; Cerebral Revascularization; Cerebrovascular Circu | 1998 |
Effect of acetazolamide reactivity and long-term outcome in patients with major cerebral artery occlusive diseases.
Topics: Acetazolamide; Arterial Occlusive Diseases; Brain Ischemia; Cerebral Arteries; Cerebrovascular Circu | 1998 |
Laser-Doppler scanning of local cerebral blood flow and reserve capacity and testing of motor and memory functions in a chronic 2-vessel occlusion model in rats.
Topics: Acetazolamide; Animals; Anticonvulsants; Arterial Occlusive Diseases; Behavior, Animal; Blood Pressu | 1998 |
The discrepancy between 99Tcm-ECD dynamic and static SPET images in patients with ischaemic lesions corresponds to reduced vasoreactivity to acetazolamide.
Topics: Acetazolamide; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Brain; Brain Ischemia; Carotid | 1998 |
Influence of acetazolamide and CO2 on extracranial flow volume and intracranial blood flow velocity.
Topics: Acetazolamide; Aged; Arterial Occlusive Diseases; Blood Flow Velocity; Brain; Carbon Dioxide; Cerebr | 1999 |
Spontaneous improvement in reduced vasodilatory capacity in major cerebral arterial occlusive disease.
Topics: Acetazolamide; Adult; Aged; Anticonvulsants; Arterial Occlusive Diseases; Brain Ischemia; Cerebral A | 2000 |
Measurement of cerebral hemodynamics with perfusion-weighted MR imaging: comparison with pre- and post-acetazolamide 133Xe-SPECT in occlusive carotid disease.
Topics: Acetazolamide; Aged; Arterial Occlusive Diseases; Blood Volume; Carotid Artery Diseases; Carotid Ste | 2001 |
Correlation of cerebrovascular reserve as measured by acetazolamide-challenged SPECT with angiographic flow patterns and intra- or extracranial arterial stenosis.
Topics: Acetazolamide; Aged; Aged, 80 and over; Arachnoid; Arterial Occlusive Diseases; Basilar Artery; Caro | 2001 |
Dynamic CT perfusion imaging with acetazolamide challenge for the preprocedural evaluation of a patient with symptomatic middle cerebral artery occlusive disease.
Topics: Acetazolamide; Angiography, Digital Subtraction; Arterial Occlusive Diseases; Cerebral Angiography; | 2002 |
CBF and transcranial Doppler sonography during vasodilatory stress tests in patients with common carotid artery occlusion.
Topics: Acetazolamide; Aged; Arterial Occlusive Diseases; Carbon Dioxide; Carotid Artery Diseases; Cerebrova | 1992 |
99mTc-HMPAO-SPECT with acetazolamide challenge to detect hemodynamic compromise in occlusive cerebrovascular disease.
Topics: Acetazolamide; Adult; Aged; Arterial Occlusive Diseases; Cerebral Angiography; Cerebrovascular Disor | 1992 |
Evaluation of cerebral vasomotor reactivity by various vasodilating stimuli: comparison of CO2 to acetazolamide.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Carbon Dioxide; Carotid | 1992 |
Carotid artery disease: evaluation with acetazolamide-enhanced Tc-99m HMPAO SPECT.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Carotid Artery Diseases; | 1992 |
[The responses of somatosensory evoked potentials and cerebral blood flow to acetazolamide in patients with occlusive carotid disease].
Topics: Acetazolamide; Adult; Aged; Arterial Occlusive Diseases; Carotid Artery Diseases; Cerebrovascular Ci | 1991 |
Hemodynamics of carotid occlusive disease.
Topics: Acetazolamide; Arterial Occlusive Diseases; Carotid Arteries; Carotid Artery Diseases; Cerebrovascul | 1990 |
[Measurement of cerebral blood flow by single photon emission computed tomography in cases of internal carotid artery occlusion].
Topics: Acetazolamide; Administration, Inhalation; Adolescent; Adult; Aged; Arterial Occlusive Diseases; Car | 1989 |
Regional cerebral blood flow (rCBF) and cerebral vasoreactivity in patients with retinal ischaemic symptoms.
Topics: Acetazolamide; Adult; Aged; Angiography; Arterial Occlusive Diseases; Arteriosclerosis; Blindness; C | 1989 |